Lin Cai

1.3k total citations
39 papers, 1.0k citations indexed

About

Lin Cai is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lin Cai has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Cancer Research and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lin Cai's work include Pituitary Gland Disorders and Treatments (12 papers), Glioma Diagnosis and Treatment (8 papers) and MicroRNA in disease regulation (6 papers). Lin Cai is often cited by papers focused on Pituitary Gland Disorders and Treatments (12 papers), Glioma Diagnosis and Treatment (8 papers) and MicroRNA in disease regulation (6 papers). Lin Cai collaborates with scholars based in China, United States and Thailand. Lin Cai's co-authors include Zhe Wu, Shao Jian Lin, Zhipeng Su, Weiming Zheng, Yu Guo, Han Bing Shang, Wei Zhao, Zhi Peng Su, Qi Chuan Zhuge and Yu Yao and has published in prestigious journals such as Nature Communications, Neurology and Brain Research.

In The Last Decade

Lin Cai

39 papers receiving 998 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Cai China 18 557 376 260 176 156 39 1.0k
Katja Kiseljak‐Vassiliades United States 20 398 0.7× 354 0.9× 532 2.0× 194 1.1× 109 0.7× 48 1.2k
Nguyen C. Pham United States 8 611 1.1× 224 0.6× 244 0.9× 106 0.6× 69 0.4× 11 1.1k
Jan‐Marcus Daniel Germany 15 609 1.1× 191 0.5× 71 0.3× 66 0.4× 50 0.3× 31 992
Steven Messina‐Graham United States 8 351 0.6× 116 0.3× 67 0.3× 161 0.9× 156 1.0× 10 937
Ferdous M. Barlaskar United States 8 258 0.5× 260 0.7× 172 0.7× 80 0.5× 45 0.3× 10 697
Claudia Abbruzzese Italy 20 619 1.1× 159 0.4× 54 0.2× 107 0.6× 131 0.8× 36 950
Lei Gong China 16 259 0.5× 159 0.4× 118 0.5× 37 0.2× 79 0.5× 38 679
Rosa Aledo Spain 20 507 0.9× 166 0.4× 39 0.1× 67 0.4× 85 0.5× 36 882
Carolyn Algire Germany 12 936 1.7× 340 0.9× 159 0.6× 21 0.1× 91 0.6× 16 1.2k
Robert V. Martinez United States 14 524 0.9× 113 0.3× 70 0.3× 34 0.2× 152 1.0× 22 901

Countries citing papers authored by Lin Cai

Since Specialization
Citations

This map shows the geographic impact of Lin Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Cai more than expected).

Fields of papers citing papers by Lin Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Cai. The network helps show where Lin Cai may publish in the future.

Co-authorship network of co-authors of Lin Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Cai. A scholar is included among the top collaborators of Lin Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Cai. Lin Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Zhe, Jinghao Chen, Yu Zhang, et al.. (2024). Biliverdin improved angiogenesis and suppressed apoptosis via PI3K/Akt-mediated Nrf2 antioxidant system to promote ischemic flap survival. Free Radical Biology and Medicine. 225. 35–52. 11 indexed citations
2.
Yao, Hong-Juan, et al.. (2024). New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6). 189220–189220. 5 indexed citations
3.
Cai, Lin, Lei Cao, Jianglong Lu, et al.. (2022). ACT001 inhibits pituitary tumor growth by inducing autophagic cell death via MEK4/MAPK pathway. Acta Pharmacologica Sinica. 43(9). 2386–2396. 9 indexed citations
4.
Cai, Lin, Yingyu Chen, Silu Wang, et al.. (2021). Brusatol Inhibits Proliferation and Invasion of Glioblastoma by Down-Regulating the Expression of ECM1. Frontiers in Pharmacology. 12. 775680–775680. 14 indexed citations
5.
Cai, Lin, Jian Chen, Jianglong Lu, et al.. (2021). Tumor stem-like cells isolated from MMQ cells resist to dopamine agonist treatment. Molecular and Cellular Endocrinology. 535. 111396–111396. 3 indexed citations
6.
Cai, Lin, et al.. (2020). Calpain suppresses cell growth and invasion of glioblastoma multiforme by producing the cleavage of filamin A. International Journal of Clinical Oncology. 25(6). 1055–1066. 7 indexed citations
7.
Li, Qun, Yong Zhang, Lin Cai, et al.. (2020). The long noncoding RNA-H19/miRNA-93a/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonists. Molecular and Cellular Endocrinology. 518. 111033–111033. 25 indexed citations
8.
Wang, Chengde, Chunyong Wang, Qun Li, et al.. (2020). A Quantified Risk-Scoring System for the Recurrence of Meningiomas: Results From a Retrospective Study of 392 Patients. Frontiers in Oncology. 10. 585313–585313. 5 indexed citations
9.
Lu, Jianglong, Qun Li, Lin Cai, et al.. (2018). RBM17 controls apoptosis and proliferation to promote Glioma progression. Biochemical and Biophysical Research Communications. 505(1). 20–28. 12 indexed citations
10.
Liu, Zhengjun, et al.. (2018). IGF2BP1 over-expression in skin squamous cell carcinoma cells is essential for cell growth. Biochemical and Biophysical Research Communications. 501(3). 731–738. 33 indexed citations
11.
Su, Zhipeng, et al.. (2017). MicroRNA-342 inhibits the progression of glioma by directly targeting PAK4. Oncology Reports. 38(2). 1240–1250. 14 indexed citations
12.
Su, Zhipeng, Lin Cai, Jianglong Lu, et al.. (2017). Global expression profile of tumor stem-like cells isolated from MMQ rat prolactinoma cell. Cancer Cell International. 17(1). 15–15. 8 indexed citations
13.
Cai, Lin, et al.. (2017). CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma. Molecular Medicine Reports. 15(4). 1713–1721. 18 indexed citations
14.
Xu, Jianjun, et al.. (2016). Risk factors for ulceration over tophi in patients with gout. International Wound Journal. 14(4). 704–707. 7 indexed citations
15.
Wu, Zhe, Lin Cai, Shao Jian Lin, et al.. (2015). Heat Shock Protein 47 Promotes Glioma Angiogenesis. Brain Pathology. 26(1). 31–42. 38 indexed citations
16.
Cai, Lin, Yu Guo, Shao Jian Lin, et al.. (2015). Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas. Endocrine. 52(3). 641–651. 17 indexed citations
17.
Wu, Zhe, Lin Cai, Shao Jian Lin, et al.. (2013). High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance. Neuro-Oncology. 15(9). 1264–1275. 41 indexed citations
18.
Wu, Zhe, et al.. (2013). The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas. Brain Research. 1529. 16–25. 58 indexed citations
19.
Chen, Yong, et al.. (2013). Gamma knife surgery for patients with volumetric classification of nonfunctioning pituitary adenomas: a systematic review and meta-analysis. European Journal of Endocrinology. 169(4). 487–495. 15 indexed citations
20.
Chen, Yong, et al.. (2012). Natural History of Postoperative Nonfunctioning Pituitary Adenomas: A Systematic Review and Meta-Analysis. Neuroendocrinology. 96(4). 333–342. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katja Kiseljak‐Vassiliades Breakdown of academic impact, for papers by Nguyen C. Pham Breakdown of academic impact, for papers by Jan‐Marcus Daniel Breakdown of academic impact, for papers by Steven Messina‐Graham Breakdown of academic impact, for papers by Ferdous M. Barlaskar Breakdown of academic impact, for papers by Claudia Abbruzzese Breakdown of academic impact, for papers by Lei Gong Breakdown of academic impact, for papers by Rosa Aledo Breakdown of academic impact, for papers by Carolyn Algire Breakdown of academic impact, for papers by Robert V. Martinez
Rankless by CCL
2026